| ESMAX | VESIX | ESMAX / VESIX | |
| Total Expense Ratio | 1.25 | 0.06 | 2,083% |
| Annual Report Gross Expense Ratio | 1.44 | 0.06 | 2,400% |
| Fund Existence | 26 years | 26 years | - |
| Gain YTD | 12.201 | 8.756 | 139% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 37.9B | 0% |
| Annual Yield % from dividends | 3.16 | 2.83 | 111% |
| Returns for 1 year | -14.44 | 20.48 | -71% |
| Returns for 3 years | 6.88 | 45.64 | 15% |
| Returns for 5 years | -6.87 | 33.88 | -20% |
| Returns for 10 years | 41.74 | 95.80 | 44% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GFFDX | 86.21 | 1.51 | +1.78% |
| Invesco Global Focus R5 | |||
| CMGSX | 28.23 | 0.11 | +0.39% |
| BlackRock Mid-Cap Growth Equity Svc | |||
| FBAFX | 40.42 | 0.07 | +0.17% |
| American Funds American Balanced 529-F-2 | |||
| VSFIX | 29.69 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value IS | |||
| PHSZX | 50.32 | -0.58 | -1.14% |
| PGIM Jennison Health Sciences Z | |||